ArticlePloS one2025
Deep crypt secretory cells shape region-specific mucin glycosylation patterns in the mouse colon.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Intestinal Fucosylation: A Key Regulatory Hub in Homeostasis and Disease Pathogenesis.Biomolecules · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The colonic mucin layer, comprising highly glycosylated mucin proteins, is crucial for maintaining colonic health. Its region-specific glycosylation patterns are indispensable for adapting to distinct physiological and microbial environments along the colon, thus ensuring appropriate mucin layer function. However, the mechanisms underlying this region-specific glycosylation remain unknown. Here, using fluorescence-based immunohistological analyses of the colon from experimental mice, we demonstrated that along with contribution of goblet cells, as conventionally believed, mucin glycosylation involves deep crypt secretory (DCS) cells, a specialized mucin-producing cell population in the colon. Based on cKit/CD117 as a DCS cell marker, DCS and goblet cells are inversely distributed along the mouse colon: DCS cells predominate proximally, constituting nearly 70% of mucin-producing cells, whereas goblet cells are more abundant distally, indicating a dynamic shift in the predominant mucin-producing cell population along the colon. Immunofluorescence staining revealed that DCS cells produce distinctive mucin-glycans, including those with the Core3-glycan motif that exhibit region-specific distributions in the mucin layer. We found that the gradient distribution of DCS cells predominantly shapes their region-specific distribution, whereas the inverse distribution of goblet cells corresponds to the distal distribution of sulfated and sialylated glycans. Furthermore, the in situ Proximity Ligation Assay for specifically detecting Muc2 with distinct glycosylation, revealed that DCS and goblet cells produce different types of α1,2-fucosylated glycans on Muc2, indicating that the shift in the predominant mucin-producing cells drives region-specific α1,2-fucosylation on Muc2 across colonic regions. Although DCS cells are implicated in supporting the stem cell niche, their involvement in mucin production was unclear. We highlight the critical role of DCS cells in establishing regional glycosylation patterns. Our findings provide new insights into the cellular basis of mucin glycosylation, as well as their potential impact on colonic health and disease susceptibility in specific colonic regions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.